3-D Matrix EMEA

3-D Matrix EMEA is the European branch of 3-D Matrix, a global company specializing in medical devices and peptide solutions. Founded in 2004 as a spin-off from MIT, the company is headquartered in Tokyo, Japan, with a significant research and development facility in Woburn, Massachusetts. It operates worldwide, with offices in Europe, America, and Asia, including its EMEA office in Hoofddorp, The Netherlands. The company’s core technology is based on self-assembling peptides, which are used in their flagship product, PuraStat. This haemostatic agent is designed to control bleeding during surgical procedures. 3-D Matrix also offers synthetic extracellular matrix products for laboratory applications, promoting cell culture and tissue regeneration. Their mission is to innovate treatment options that improve patient outcomes, emphasizing collaboration with academic and commercial partners to advance clinical and laboratory applications.

• Employees 110
• Founded 2002
• Annual Revenue $48519000